FEBU
Fellow of the European Board of Urology
Metastatic Prostate CancerEnglish
Exam overviewPractice session
A 64-year-old man presents with de novo metastatic hormone-sensitive prostate cancer with multiple bone metastases, good performance status and no major contraindication to systemic therapy. Which principle should guide first-line treatment?
Loading your practice session…